跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ampholip - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ampholip
Approved
STANDARD
Ampholip
Bharat Serums and Vaccine Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0f9561f2bbf9b0f4
Company
Bharat Serums and Vaccine Limited
Type
Standard
Approval Details
Approval Id
0f9561f2bbf9b0f4
Drug Approval Philippines Name
Ampholip
Product Name
Ampholip
Registration Number
DR-XY35140
Brand Name
Ampholip
Generic Name
Amphotericin B
Dosage Form
Lipid Complex Suspension for Injection (IV)
Dosage Strength
5mg/mL (50mg/10mL)
Manufacturer
Bharat Serums and Vaccine Limited
Importer
BSV Bioscience Philippines Inc.
Distributor
Sandoval Distributors Inc.
Issuance Date
26 June 2020
Expiry Date
11 November 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0f9561f2bbf9b0f4
Type
Standard
Back to Philippines FDA Approvals